Sana Biotechnology raises more than $700M for cell, gene therapy efforts

Sana Biotechnology raises more than $700M for cell, gene therapy efforts

Source: 
MedCity News
snippet: 

The co-founders of the company include Hans Bishop, who founded Juno Therapeutics - one of the earliest commercial developers of CAR-T cell therapy technology - in 2013.